Radiotherapy Followed by Adjuvant Chemotherapy in NK/T-cell Lymphoma
Condition(s):Extranodal NK/T-cell Lymphoma, Nasal TypeLast Updated:March 5, 2013Unknown status
Hide Studies Not Open or Pending
Condition(s):Extranodal NK/T-cell Lymphoma, Nasal TypeLast Updated:March 5, 2013Unknown status
Condition(s):Extranodal NK-T-Cell Lymphoma, Nasal TypeLast Updated:September 14, 2021Completed
Condition(s):Recurrent Pediatric ALL; Relapsed Pediatric ALL; Acute Lymphoblastic Leukemia; Refractory Pediatric ALLLast Updated:March 17, 2021Terminated
Condition(s):Hemophagocytic LymphohistiocytosisLast Updated:September 23, 2016Unknown status
Condition(s):Extranodal NK/T-cell LymphomaLast Updated:November 9, 2023Not yet recruiting
Condition(s):Lymphoma, Extranodal NK-T-CellLast Updated:May 9, 2018Terminated
Condition(s):Drug/Agent Toxicity by Tissue/Organ; LeukemiaLast Updated:November 3, 2023Completed
Condition(s):Natural Killer/T-Cell Lymphoma, Nasal and Nasal-TypeLast Updated:March 4, 2024Completed
Condition(s):Leukemia; Leukemia, Acute; Adult Lymphoblastic Lymphoma; Leukemia, Lymphoblastic; Leukemia, T Cell; Adult Acute Lymphoblastic Leukemia; Lymphoblastic Lymphoma; Lymphoblastic LeukemiaLast Updated:June 21, 2018Unknown status
Condition(s):Acute Lymphoblastic Leukemia; Lymphoblastic LymphomaLast Updated:June 23, 2021Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.